WO1996016334A3 - Screening technique - Google Patents
Screening technique Download PDFInfo
- Publication number
- WO1996016334A3 WO1996016334A3 PCT/GB1995/002732 GB9502732W WO9616334A3 WO 1996016334 A3 WO1996016334 A3 WO 1996016334A3 GB 9502732 W GB9502732 W GB 9502732W WO 9616334 A3 WO9616334 A3 WO 9616334A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- tumour cells
- inhibitor
- cells
- sample
- guanidinobenzoatase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/974—Thrombin
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Urology & Nephrology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Hospice & Palliative Care (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU38784/95A AU3878495A (en) | 1994-11-23 | 1995-11-23 | Screening technique |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9423615.5 | 1994-11-23 | ||
GB9423616.3 | 1994-11-23 | ||
GB9423617.1 | 1994-11-23 | ||
GB9423617A GB9423617D0 (en) | 1994-11-23 | 1994-11-23 | Preparation of cell samples |
GB9423616A GB9423616D0 (en) | 1994-11-23 | 1994-11-23 | Screening technique |
GB9423615A GB9423615D0 (en) | 1994-11-23 | 1994-11-23 | Screening technique |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1996016334A2 WO1996016334A2 (en) | 1996-05-30 |
WO1996016334A3 true WO1996016334A3 (en) | 1996-08-01 |
Family
ID=27267483
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB1995/002732 WO1996016334A2 (en) | 1994-11-23 | 1995-11-23 | Screening technique |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU3878495A (en) |
WO (1) | WO1996016334A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2553637T3 (en) * | 2006-03-06 | 2015-12-10 | Zetiq Technologies Ltd. | Methods to identify a cellular phenotype |
US9182403B2 (en) | 2009-05-19 | 2015-11-10 | Zetiq Technologies Ltd. | Kits for and methods of differential staining of cervical cancer cells and/or tissues |
-
1995
- 1995-11-23 WO PCT/GB1995/002732 patent/WO1996016334A2/en active Application Filing
- 1995-11-23 AU AU38784/95A patent/AU3878495A/en not_active Abandoned
Non-Patent Citations (14)
Title |
---|
ANTICANCER RES., vol. 11, no. 1, pages 143 - 150 * |
ANTICANCER RES., vol. 8, no. 6, pages 1179 - 1183 * |
BIOCHEM. SOC. TRANS., vol. 15, no. 6, pages 1109 * |
BIOL. CHEM. HOPPE-SEYLER, vol. 369(suppl.), pages 137 - 143 * |
CHEMICAL ABSTRACTS, vol. 107, no. 15, 12 October 1987, Columbus, Ohio, US; abstract no. 131847, F. S. STEVEN ET AL.: "Evidence for in vivo inhibition of a cell surface protease associated with tumor cells." page 517; column 2; * |
CHEMICAL ABSTRACTS, vol. 108, no. 15, 11 April 1988, Columbus, Ohio, US; abstract no. 127378, F. S. STEVEN ET AL.: "Inhibitors of guanidinobenzoatase: evidence for multiple forms of this protease on different tumor cells." page 341; column 1; * |
CHEMICAL ABSTRACTS, vol. 109, no. 9, 29 August 1988, Columbus, Ohio, US; abstract no. 70869, F. S. STEVEN ET AL.: "Inhibitors of guanidinobenzoatase and their possible role in cell migration." page 458; column 1; * |
CHEMICAL ABSTRACTS, vol. 110, no. 25, 19 June 1989, Columbus, Ohio, US; abstract no. 225086, F. STEVEN ET AL.: "A fluorescent study of ligands for guanidinobenzoatase, a protease associated with tumor cells." page 23; column 2; * |
CHEMICAL ABSTRACTS, vol. 115, no. 3, 22 July 1991, Columbus, Ohio, US; abstract no. 26918, F. S. STEVEN ET AL.: "Evidence for distinct isoenzymic forms of a cell surface protease on normal colonic cells and on carcinoma cells from the same colon." page 550; column 1; * |
CHEMICAL ABSTRACTS, vol. 115, no. 5, 5 August 1991, Columbus, Ohio, US; abstract no. 44714, F. S. STEVEN ET AL.: "Temporary competitive inhibition of a tumor cell surface protease as a protective mechanism in the preparation of the membrane bound native enzyme in the presence of excess cytoplasmic inhibitors." page 367; column 2; * |
CHEMICAL ABSTRACTS, vol. 120, no. 3, 17 January 1994, Columbus, Ohio, US; abstract no. 26195, F. S. STEVEN ET AL.: "Affinity preparation of a protein inhibitor recognizing a cell surface protease" page 368; column 1; * |
J. ENZYME INHIB., vol. 2, no. 2, pages 117 - 127 * |
J. ENZYME INHIB., vol. 5, no. 1, pages 77 - 85 * |
J. ENZYME INHIB., vol. 7, no. 1, pages 65 - 76 * |
Also Published As
Publication number | Publication date |
---|---|
AU3878495A (en) | 1996-06-17 |
WO1996016334A2 (en) | 1996-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0797777A4 (en) | Device for performing one or more competitive immunoassays | |
CA2249638A1 (en) | Kit and method for fluorescence based detection assay | |
WO2003091394A3 (en) | Methods and kits for detecting a target cell | |
ITTO20010411A0 (en) | METHOD AND DEVICE FOR PERFORMING HIGH PROCESSIVE AND HIGH BIOLOGICAL VALUE TEST AND ASSAY ON CELLS AND/OR COMPOUNDS. | |
DK0943097T3 (en) | Method of Detecting IgE | |
AU1674400A (en) | Kidney disease detection and treatment | |
HK1041922A1 (en) | An assay to detect a binding partner | |
WO2003048300A3 (en) | Methods of identifying cellular target molecules | |
DE69734646D1 (en) | METHOD FOR FORGING FAULTS OF BOWS, BANKNOTES ETC., AND METHOD FOR ASSESSING ITS INTRODUCTION DIRECTION | |
DE69930404D1 (en) | METHOD FOR THE DETECTION OF ANALYTES | |
ATE322550T1 (en) | METHOD FOR DETERMINING THE PRESENCE OF BACTERIA RESISTANT TO CELL-LYSING ANTIBIOTICS | |
IL143098A0 (en) | A method of detecting the presence of an analyte in a biological sample | |
CA2339821A1 (en) | Enzymatic measurement of mycophenolic acid | |
WO2000007017A3 (en) | Method of high-throughput screening | |
DE69732034D1 (en) | ASSAY METHOD | |
EP2088206A3 (en) | Induction of the mitochondrial permeability transition | |
DE69128639D1 (en) | METHOD AND PHARMACEUTICAL SETS FOR DETECTING MICROORGANISMS ASSOCIATED WITH VAGINAL INFECTIONS | |
CA2407760A1 (en) | Methods for diagnosis of low grade astrocytoma | |
WO1996016334A3 (en) | Screening technique | |
WO1998029726A3 (en) | Method of detecting and determining the concentration of total troponin i in a biological sample | |
DE60332479D1 (en) | HOLO-TRANSCOBALAMIN BINDING PARTNER AND ITS USE IN COBALAMINTEST | |
WO2002044417A3 (en) | Expression analysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer | |
WO2001091629A3 (en) | Methods for detecting dna damage and screening for cancer therapeutics | |
AU2261601A (en) | Method for the simultaneous analysis and detection of multiple analytes by microidentification | |
WO2001014593A3 (en) | A method for producing quality assured biological sample and composition containing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TT UA UG US UZ VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AT AU BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TT UA UG US UZ VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: CA |